Household & Personal Products
Compare Stocks
4 / 10Stock Comparison
EPC vs CHD vs PG vs CL
Revenue, margins, valuation, and 5-year total return — side by side.
Household & Personal Products
Household & Personal Products
Household & Personal Products
EPC vs CHD vs PG vs CL — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Household & Personal Products | Household & Personal Products | Household & Personal Products | Household & Personal Products |
| Market Cap | $1.01B | $22.24B | $341.30B | $70.09B |
| Revenue (TTM) | $2.11B | $6.21B | $86.72B | $20.38B |
| Net Income (TTM) | $-78M | $733M | $12.72B | $2.13B |
| Gross Margin | 40.6% | 45.1% | 50.3% | 60.1% |
| Operating Margin | 1.7% | 17.3% | 23.2% | 21.3% |
| Forward P/E | 11.4x | 25.0x | 21.1x | 22.9x |
| Total Debt | $1.54B | $2.21B | $35.46B | $7.99B |
| Cash & Equiv. | $226M | $409M | $9.56B | $1.29B |
EPC vs CHD vs PG vs CL — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Edgewell Personal C… (EPC) | 100 | 71.2 | -28.8% |
| Church & Dwight Co.… (CHD) | 100 | 125.1 | +25.1% |
| The Procter & Gambl… (PG) | 100 | 126.0 | +26.0% |
| Colgate-Palmolive C… (CL) | 100 | 120.8 | +20.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: EPC vs CHD vs PG vs CL
Each card shows where this stock fits in a portfolio — not just who wins on paper.
EPC has the current edge in this matchup, primarily because of its strength in defensive.
- Beta 0.79, yield 2.8%, current ratio 1.76x
- Lower P/E (11.4x vs 21.1x)
- 2.8% yield, 2-year raise streak, vs PG's 2.8%
CHD is the #2 pick in this set and the best alternative if growth exposure and sleep-well-at-night is your priority.
- Rev growth 1.6%, EPS growth 27.4%, 3Y rev CAGR 4.9%
- Lower volatility, beta 0.14, Low D/E 55.1%, current ratio 1.07x
- 1.6% revenue growth vs EPC's -1.3%
- +3.4% vs EPC's -17.6%
PG is the clearest fit if your priority is income & stability and long-term compounding.
- Dividend streak 36 yrs, beta 0.10, yield 2.8%
- 119.3% 10Y total return vs CHD's 113.6%
- 14.7% margin vs EPC's -3.7%
- Beta 0.10 vs EPC's 0.79, lower leverage
CL is the clearest fit if your priority is efficiency.
- 12.5% ROA vs EPC's -2.1%, ROIC 43.4% vs 2.6%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 1.6% revenue growth vs EPC's -1.3% | |
| Value | Lower P/E (11.4x vs 21.1x) | |
| Quality / Margins | 14.7% margin vs EPC's -3.7% | |
| Stability / Safety | Beta 0.10 vs EPC's 0.79, lower leverage | |
| Dividends | 2.8% yield, 2-year raise streak, vs PG's 2.8% | |
| Momentum (1Y) | +3.4% vs EPC's -17.6% | |
| Efficiency (ROA) | 12.5% ROA vs EPC's -2.1%, ROIC 43.4% vs 2.6% |
EPC vs CHD vs PG vs CL — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
EPC vs CHD vs PG vs CL — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
PG leads in 1 of 6 categories
EPC leads 1 • CL leads 1 • CHD leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
PG leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
PG is the larger business by revenue, generating $86.7B annually — 41.2x EPC's $2.1B. PG is the more profitable business, keeping 14.7% of every revenue dollar as net income compared to EPC's -3.7%. On growth, PG holds the edge at +7.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $2.1B | $6.2B | $86.7B | $20.4B |
| EBITDAEarnings before interest/tax | $80M | $1.3B | $21.9B | $3.9B |
| Net IncomeAfter-tax profit | -$78M | $733M | $12.7B | $2.1B |
| Free Cash FlowCash after capex | $49M | $1.1B | $15.0B | $3.6B |
| Gross MarginGross profit ÷ Revenue | +40.6% | +45.1% | +50.3% | +60.1% |
| Operating MarginEBIT ÷ Revenue | +1.7% | +17.3% | +23.2% | +21.3% |
| Net MarginNet income ÷ Revenue | -3.7% | +11.8% | +14.7% | +10.5% |
| FCF MarginFCF ÷ Revenue | +2.3% | +17.2% | +17.3% | +17.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | -10.5% | +0.1% | +7.4% | +5.8% |
| EPS Growth (YoY)Latest quarter vs prior year | -136.7% | +2.2% | +5.8% | -105.1% |
Valuation Metrics
EPC leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
At 22.4x trailing earnings, PG trades at a 45% valuation discount to EPC's 40.8x P/E. On an enterprise value basis, EPC's 12.6x EV/EBITDA is more attractive than CHD's 18.1x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $1.0B | $22.2B | $341.3B | $70.1B |
| Enterprise ValueMkt cap + debt − cash | $2.3B | $24.0B | $367.2B | $76.8B |
| Trailing P/EPrice ÷ TTM EPS | 40.84x | 31.09x | 22.44x | 33.22x |
| Forward P/EPrice ÷ next-FY EPS est. | 11.41x | 25.01x | 21.14x | 22.88x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 4.01x | — |
| EV / EBITDAEnterprise value multiple | 12.56x | 18.14x | 15.76x | 15.43x |
| Price / SalesMarket cap ÷ Revenue | 0.45x | 3.59x | 4.05x | 3.44x |
| Price / BookPrice ÷ Book value/share | 0.66x | 5.73x | 6.86x | 194.13x |
| Price / FCFMarket cap ÷ FCF | 24.42x | 20.35x | 24.30x | 19.29x |
Profitability & Efficiency
CL leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
CL delivers a 2.5% return on equity — every $100 of shareholder capital generates $3 in annual profit, vs $-5 for EPC. CHD carries lower financial leverage with a 0.55x debt-to-equity ratio, signaling a more conservative balance sheet compared to CL's 21.88x. On the Piotroski fundamental quality scale (0–9), CHD scores 7/9 vs PG's 5/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -5.1% | +17.4% | +23.8% | +2.5% |
| ROA (TTM)Return on assets | -2.1% | +8.2% | +10.0% | +12.5% |
| ROICReturn on invested capital | +2.6% | +13.9% | +20.1% | +43.4% |
| ROCEReturn on capital employed | +3.0% | +14.4% | +23.0% | +41.6% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 7 | 5 | 6 |
| Debt / EquityFinancial leverage | 0.99x | 0.55x | 0.68x | 21.88x |
| Net DebtTotal debt minus cash | $1.3B | $1.8B | $25.9B | $6.7B |
| Cash & Equiv.Liquid assets | $226M | $409M | $9.6B | $1.3B |
| Total DebtShort + long-term debt | $1.5B | $2.2B | $35.5B | $8.0B |
| Interest CoverageEBIT ÷ Interest expense | 0.01x | 15.59x | 487.21x | 12.37x |
Total Returns (Dividends Reinvested)
Evenly matched — PG and CL each lead in 2 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in PG five years ago would be worth $12,240 today (with dividends reinvested), compared to $5,654 for EPC. Over the past 12 months, CHD leads with a +3.4% total return vs EPC's -17.6%. The 3-year compound annual growth rate (CAGR) favors CL at 5.0% vs EPC's -18.4% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +29.3% | +14.0% | +4.5% | +13.8% |
| 1-Year ReturnPast 12 months | -17.6% | +3.4% | -5.6% | -1.6% |
| 3-Year ReturnCumulative with dividends | -45.6% | +0.7% | +1.9% | +15.7% |
| 5-Year ReturnCumulative with dividends | -43.5% | +13.7% | +22.4% | +18.2% |
| 10-Year ReturnCumulative with dividends | -68.2% | +113.6% | +119.3% | +47.0% |
| CAGR (3Y)Annualised 3-year return | -18.4% | +0.2% | +0.6% | +5.0% |
Risk & Volatility
Evenly matched — CHD and CL each lead in 1 of 2 comparable metrics.
Risk & Volatility
CL is the less volatile stock with a -0.00 beta — it tends to amplify market swings less than EPC's 0.79 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CHD currently trades 88.5% from its 52-week high vs EPC's 74.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.79x | 0.14x | 0.10x | -0.00x |
| 52-Week HighHighest price in past year | $28.92 | $106.04 | $170.99 | $99.33 |
| 52-Week LowLowest price in past year | $15.88 | $81.33 | $137.62 | $74.55 |
| % of 52W HighCurrent price vs 52-week peak | +74.8% | +88.5% | +85.4% | +87.9% |
| RSI (14)Momentum oscillator 0–100 | 51.2 | 49.1 | 53.7 | 58.1 |
| Avg Volume (50D)Average daily shares traded | 662K | 1.8M | 7.2M | 5.6M |
Analyst Outlook
Evenly matched — EPC and PG each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: EPC as "Hold", CHD as "Buy", PG as "Buy", CL as "Hold". Consensus price targets imply 10.8% upside for PG (target: $162) vs 6.1% for CHD (target: $100). For income investors, EPC offers the higher dividend yield at 2.84% vs CHD's 1.25%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | $23.67 | $99.60 | $161.88 | $93.70 |
| # AnalystsCovering analysts | 17 | 34 | 52 | 45 |
| Dividend YieldAnnual dividend ÷ price | +2.8% | +1.3% | +2.8% | +2.6% |
| Dividend StreakConsecutive years of raises | 2 | 23 | 36 | 5 |
| Dividend / ShareAnnual DPS | $0.62 | $1.18 | $4.02 | $2.25 |
| Buyback YieldShare repurchases ÷ mkt cap | +8.9% | +4.0% | +1.9% | +1.7% |
PG leads in 1 of 6 categories (Income & Cash Flow). EPC leads in 1 (Valuation Metrics). 3 tied.
EPC vs CHD vs PG vs CL: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is EPC or CHD or PG or CL a better buy right now?
For growth investors, Church & Dwight Co.
, Inc. (CHD) is the stronger pick with 1. 6% revenue growth year-over-year, versus -1. 3% for Edgewell Personal Care Company (EPC). The Procter & Gamble Company (PG) offers the better valuation at 22. 4x trailing P/E (21. 1x forward), making it the more compelling value choice. Analysts rate Church & Dwight Co. , Inc. (CHD) a "Buy" — based on 34 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — EPC or CHD or PG or CL?
On trailing P/E, The Procter & Gamble Company (PG) is the cheapest at 22.
4x versus Edgewell Personal Care Company at 40. 8x. On forward P/E, Edgewell Personal Care Company is actually cheaper at 11. 4x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — EPC or CHD or PG or CL?
Over the past 5 years, The Procter & Gamble Company (PG) delivered a total return of +22.
4%, compared to -43. 5% for Edgewell Personal Care Company (EPC). Over 10 years, the gap is even starker: PG returned +119. 3% versus EPC's -68. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — EPC or CHD or PG or CL?
By beta (market sensitivity over 5 years), Colgate-Palmolive Company (CL) is the lower-risk stock at -0.
00β versus Edgewell Personal Care Company's 0. 79β — meaning EPC is approximately -18107% more volatile than CL relative to the S&P 500. On balance sheet safety, Church & Dwight Co. , Inc. (CHD) carries a lower debt/equity ratio of 55% versus 22% for Colgate-Palmolive Company — giving it more financial flexibility in a downturn.
05Which is growing faster — EPC or CHD or PG or CL?
By revenue growth (latest reported year), Church & Dwight Co.
, Inc. (CHD) is pulling ahead at 1. 6% versus -1. 3% for Edgewell Personal Care Company (EPC). On earnings-per-share growth, the picture is similar: Church & Dwight Co. , Inc. grew EPS 27. 4% year-over-year, compared to -73. 1% for Edgewell Personal Care Company. Over a 3-year CAGR, CHD leads at 4. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — EPC or CHD or PG or CL?
The Procter & Gamble Company (PG) is the more profitable company, earning 19.
0% net margin versus 1. 1% for Edgewell Personal Care Company — meaning it keeps 19. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PG leads at 24. 3% versus 4. 3% for EPC. At the gross margin level — before operating expenses — CL leads at 60. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is EPC or CHD or PG or CL more undervalued right now?
On forward earnings alone, Edgewell Personal Care Company (EPC) trades at 11.
4x forward P/E versus 25. 0x for Church & Dwight Co. , Inc. — 13. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PG: 10. 8% to $161. 88.
08Which pays a better dividend — EPC or CHD or PG or CL?
All stocks in this comparison pay dividends.
Edgewell Personal Care Company (EPC) offers the highest yield at 2. 8%, versus 1. 3% for Church & Dwight Co. , Inc. (CHD).
09Is EPC or CHD or PG or CL better for a retirement portfolio?
For long-horizon retirement investors, Colgate-Palmolive Company (CL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.
00), 2. 6% yield). Both have compounded well over 10 years (CL: +47. 0%, EPC: -68. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between EPC and CHD and PG and CL?
Both stocks operate in the Consumer Defensive sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.